early stages to metastasis, in particular on regulation of energy and lipid metabolism. In addition, her laboratory investigates the mechanisms of how obesity impacts cancer development. Another research focus is the development of curricula to promote research skills in interdisciplinary research for both undergraduate and graduate students. (American Cancer Society, 2015; Yücel, et al., 2014) . In addition, studies also show 70% of patients who are diagnosed with metastatic breast cancer at an advanced stage develop bone metastasis (Ahn et.al., 2013) .
Tomasz Wilmanski
Cancer cells must break down physical barriers, including the extracellular matrix and basement membrane, in order for cancer cells to escape the primary tumor to a secondary site (thus metastasizing), which requires the expression of matrix metalloproteinases (MMPs). MMPs are zinc-dependent extracellular matrix (ECM) remodeling endopeptidases, which have the ability to degrade most components of the ECM. There are 26 known MMPs that are highly homologous yet differ in their substrate specifi cities. Each enzyme has a signal peptide to direct traffi cking through the secretory pathway and a well-conserved, compact, catalytic domain (Radisky & Radisky, 2015) . Studies show that MMPs are able to modulate the tumor microenvironment and regulate signaling pathways that control cell growth and migration, the immune system, and angiogenesis (Kessenbrock, 2010) . Imbalances in the activity of MMPs can activate cellular processes that cause DNA damage and stimulate genomic instability (Wilmanski, Buhman, Donkin, Burgess, & Teegarden, 2017) . MMPs may also directly induce phenotypic changes associated with the epithelial-mesenchymal transition, a developmental process that becomes activated during tumor progression (Wilmanski et al., 2017) . MMPs could stimulate resistance to chemotherapeutics and drive tumor progression through proteolytic inactivation of the cell death receptor Fas and consequent inhibition of the intrinsic apoptosis pathway. Furthermore, fi ndings suggest MMP overexpression may indicate a higher risk of poor prognosis in breast cancer (Ren et al., 2015) .
Evidence suggests that vitamin D may protect against breast cancer as well as breast cancer metastasis. Vitamin D can be obtained through sun exposure, food, and supplements; however, vitamin D defi ciency is prevalent in the United States The Teegarden laboratory has previously demonstrated
RESULTS
MMPs have been implicated in the processing of cytokines, growth factors, and cell adhesion molecules, demonstrating their importance in sustaining a cancer cell's migratory potential. There is also evidence that supports MMPs having a role in tumor progression and metastasis, in shaping the tumor microenvironment, and in driving cancer progression and metastasis (Radisky & Radisky, 2015) .
In order to study the impact of the active form of vitamin D, 1,25(OH) 2 D, on breast to bone metastasis, a unique 3-D cell model that recapitulates the transition steps that occur during breast cancer cell metastasis to the bone was utilized (Parikh, Belch, Pilarski, & Kirshner, 2014; Parikh, Minser, Rank, Glackin, & Kirshner, 2014) . In this model system, the metastatic cells are plated in matrigel in an upper transwell, and the transwell is inserted into a well, which contains on the bottom a coating that is similar to a bone environment. The cells were treated only in the upper well with 1,25(OH) 2 D, and the number of viable cells that implant and grow in the bone matrix was assessed. Using this model, experiments in our laboratory showed that the number of viable metastatic MCF10CA1a breast cells that successfully metastasized to the bone matrix is drastically decreased by 70% with 1,25(OH) 2 D treatment (Wilmanski et al., 2016 
METHODS

Cell Culture
In this study, MCF10CA1a cells were utilized. These cells are mammary epithelial cells that represent the metastatic stage of cancer progression with the potential to invade distant secondary organs. MCF10CA1a cells were given as a gift from Dr. Julia Kirshner (Purdue University). For these experiments, cells were cultured in DMEM/F12, 1:1 supplemented with 5% horse serum, 100-units/ml Penicillin, and 100-ug/mL streptomycin. Cells were treated with vehicle (ethanol) or 1,25(OH) 2 D (10 nm) (BIOMOL International) and delivered in 100% ethanol with a final ethanol concentration of <1%.The media was changed every 24 hours for the treatment period (Wilmanski et al., 2017) .
Scratch Wound Healing Assay
MCF10CA1a cells were plated in 6 well plates with 90% confluence and scratched with a 200 ul pipette tip. After 48 hours, the MCF10CA1a cells were treated with vehicle or 1,25(OH) 2 D (10 nM). The new media containing 0.5% serum was added containing vehicle of 1,25(OH) 2 D, and images of wound closure were taken at time 0 and 24 hours. The results were quantified through TScratch.
Real-Time Quantitative PCR
RNA was isolated with TriReagent. Reverse transcription of total RNA was performed using MMLV reverse transcriptase, and real-time quantitative PCR was performed using the Brilliant II SYBR Green QPCR Master Mix. The mRNA expression was normalized to 18S expression (Wilmanski et al., 2017) . The primers used are shown in Table 1 .
MMP1
Forward Primer AGCGTGTGACAGTAAGCTAAC Reverse Primer TCCTCAGAAAGAGCAGCATCG
MMP2
Forward Primer AGATGCCTGGAATGCCAT
Reverse Primer GGTTCTCCAGCTTCAGGTAAT
MMP3
Forward Primer GACAAAGGATACAACAGGGACCA
Reverse Primer ACCGAGTCAGGTCTGTGAGT
MMP9
Forward Primer CAACATCACCTATTGGATCC Reverse Primer CGGGTGTAGAGTCTCTCGCT
MMP13
Forward Primer TGTAAAACGACGGCCAGT
Reverse Primer CAGGAAACAGCTATGACC Table 1 . Primer sequences for MMPs.
Impact of 1,25(OH) 2 D on Migration of MCF10CA1a
The role of 1,25(OH) 2 D in the migration or movement of metastatic cells (MCF10CA1a cells) is important to understand in order to determine how metastasis is inhibited. Therefore, due to the important role of migration in metastasis, the effect of 1,25(OH) 2 D on migration of MCF10CA1a cells was examined by a wound healing assay. As shown in Figure 1 , pretreatment of cells with 1,25(OH) 2 D for 48 hours decreased cell migration by 44%±9.6 relative to vehicle. The respective images can be seen in Figure 2 .
Impact of 1,25(OH) 2 D on MMP mRNA Expression
The impact of 1,25(OH) 2 D treatment on the mRNA abundance of a variety of MMPs was investigated through real-time quantitative PCR. MMP1, MMP3, MMP9, and MMP13 mRNA levels were undetectable in MCF10CA1a cells. However, MMP2 mRNA expression levels were detectable. MMP2 mRNA abundance was significantly downregulated after 48 hours and 5 days of 1,25(OH) 2 D treatment. Treatment with 1,25(OH) 2 D (10 nM) reduced the expression of MMP2 by 32% ± 10 and 35% ± 7 at 2 and 5 days, respectively, as seen in Figure 3 .
line, with a 20% reduction in cell viability in the lower bone matrix. It is noteworthy to emphasize that there was no 1,25(OH) 2 D in the bone cell conditioned media, and thus, the altered phenotype and survival are due to the treatment in the upper well prior to movement into the bottom well. Therefore, the effects on metastasis to the bone are due, at least in part, to the treatment of the cells prior to and during invasion and migration from the upper well.
The downregulating MMP2 expression. In addition, the downregulation of MMP2 may play a role in inhibiting the migration of metastatic breast cancer cells.
Vitamin D is a food component and is synthesized by human bodies. Thus, it is a safe component to recommend for preventing metastasis. If the mechanisms of how vitamin D inhibits metastasis are determined, strategies can be developed to recommend specific intakes of the vitamin and may be targeted to specific populations to reduce the development of metastasis. Since breast cancer metastasis greatly reduces the survivability of the cancer, the impact of these studies, when translated to the clinic and general population, may have a significant impact to reduce mortality associated with breast cancer. (Ren et al., 2012; Hauser, Walsh, Shrotriya, & Karafa, 2014; Neuhouser et al., 2008; Mohr, Gorham, Kim, Hofflich, & Garland, 2014 (Rossdeutscher et al., 2014) . In addition to studies in vivo, studies in cell models also support the hypothesis that 1,25(OH) 2 D or its analogues inhibit metastasis, including invasion through matrigel and migration of MCF-7 and MCF10DCIS cells, and changes in expression of markers of metastatic capability. Therefore, evidence exist that 1,25(OH) 2 D inhibits invasive and migratory capability of breast cancer cells in vitro and the metastasis of breast cancer cells in vivo. Despite illustrating this beneficial effect, the mechanistic basis for the inhibitory action of vitamin D on breast cancer metastasis remains poorly understood. It is critical to understand this mechanism to appropriately design clinical trials with well-defined and measurable outcomes, and to determine when and to whom interventions should be targeted.
FURTHER STUDIES
Previous studies have shown the matrix metalloproteinase family to have a role in cancer and tumor metastasis. Of the 26 MMPs, MMP1, 2, 7, 9, 11, 13, and 14, along with the tissue inhibitors of MMPs, were quantified in invasive ducal breast tumors. MMP2 and MMP9 also have been examined as prognostic biomarkers in breast cancer (Radisky & Radisky, 2015) . Thus, one mechanism by which 1,25(OH) 2 D may inhibit metastasis is through downregulation of the expression of MMPs; however, this has not been examined.
The results of the current study demonstrate that 1,25(OH) 2 D can downregulate the mRNA levels of MMP2, which may lead to a potential change in the protein expression. Therefore, vitamin D through its active form, 1,25(OH) 2 D, may be an effective agent in inhibiting invasion of breast cancer cells through
